Articles Referencing ALKS

Zacks.com

SGEN's Adcetris under FDA Review - Analyst Blog

Seattle Genetics, Inc. ( SGEN ) recently announced that the US Food and Drug Administration (FDA) has accepted its supplemental biologics license application (sBLA) seeking approval of... Read >>

Zacks.com

Cempra/Toyama Ink Deal - Analyst Blog

Cempra, Inc. ( CEMP ) recently entered into an exclusive license and development agreement with a Japanese company, Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings ( FUJIY ... Read >>

Zacks.com

Much Awaited Test Launch by Genomic - Analyst Blog

Recently, Genomic Health Inc. ( GHDX ) made available its lead pipeline candidate Oncotype DX prostate cancer test to physicians and their patients. This comes as a major boost to... Read >>

Zacks.com

Myriad Soars Higher on Celeb Clout - Analyst Blog

Shares of Myriad Genetics Inc. ( MYGN ) touched a new 52-week high of $34.70 on Tuesday, May 14, 2013 following news out of Hollywood. Academy Award winning Hollywood star Angelina... Read >>

Zacks.com

Isis Gets $3.5M Milestone Payment - Analyst Blog

Isis Pharmaceuticals Inc. ( ISIS ) recently announced that it has received a milestone payment of $3.5 million from its partner, Biogen Idec Inc. ( BIIB ). The milestone payment was... Read >>

Benzinga

The Week Ahead: Full Slate of Economic Data; Earnings From Cisco, Wal-Mart and Deere

A host of economic data is set to be released for the week beginning May 13. Investors will also continue to be focused on corporate earnings reports from a number of leading companies. Heading... Read >>

Zacks.com

BioMarin Widens Loss, Maintains View - Analyst Blog

BioMarin Pharmaceutical Inc. 's ( BMRN ) first quarter 2013 loss of 31 cents per share was wider than the Zacks Consensus Estimate of a loss of 28 cents per share and the year-ago loss... Read >>

Zacks.com

Illumina Beats on Earnings, Revenue - Analyst Blog

Illumina Inc.'s ( ILMN ) first-quarter 2013 adjusted earnings of 46 cents per share beat the Zacks Consensus Estimate by 21%. Adjusted earnings grew almost 28% over the prior-year quarter... Read >>

Zacks.com

Zacks Rank #1 Addition for Tuesday - Tale of the Tape

Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List today: Alkermes Plc ( ALKS ) Allied World Assurance Co Holdings, AG ( AWH ) American National BankShares... Read >>

Zacks.com

Pipeline Progress at Alkermes - Analyst Blog

Alkermes ( ALKS ) recently announced encouraging top-line data from a phase II study (n=142) on ALKS 5461. The study evaluated the safety and efficacy of ALKS 5461 across two doses for the... Read >>

Benzinga

Market Wrap for Wednesday, April 17: Stocks Plunge Again Along With Euro

The U.S. stock market fell sharply on Wednesday as volatility continues to pick up on Wall Street. Concerns over global growth have caused the recent market gyrations that have sent the CBOE... Read >>

Benzinga

Mid-Afternoon Market Update: Markets Remain Down, ABIOMED Rises

Toward the end of trading Wednesday, the Dow traded down 0.90 percent to 14,623.12 while the NASDAQ dropped 1.93 percent to 3,201.29. The S&P also fell, declining 1.48 percent... Read >>

Benzinga

Mid-Day Market Update: Cirrus Logic Plunges On Weak Forecast, Atlas Energy Rises

Midway through trading Wednesday, the Dow traded down 1 percent to 14,609.12 while the NASDAQ dropped 1.94 percent to 3,201.29. The S&P also fell, declining 1.55 percent to 1,550.18. ... Read >>

Benzinga

Mid-Morning Market Update: Markets Move Lower, Bank of America Posts Downbeat Q1 Profit

Following the market opening Wednesday, the Dow traded down 0.62 percent to 14,665.16 while the NASDAQ dropped 0.92 percent to 3,234.63. The S&P also fell, declining 0.80 percent... Read >>

Investor's Business Daily

Biotech Alkermes Poised To Swell On Pipeline Wins

Chief Executive Richard Pops likes to make it very clear about the company he leads:Alkermes ( ALKS ) is not your run-of-the mill biotech firm. For one thing, it has a thriving commercial... Read >>

Displaying 1-15 of 49
<< first < previous 1 2 3 4 next > last >>